Changes of Functional MRI Findings in a Patient Whose Pathological Gambling Improved with Fluvoxamine by Chung, Sang-Keun et al.
Yonsei Med J   http://www.eymj.org    Volume 50   Number 3   June 2009 441
Pathological gambling has been classified as an impulse control disorder or an
obsessive-compulsive spectrum disorder.
1,2 It is a debilitating disorder with a
chronic and progressive course, and co-morbid psychiatric conditions are common
in pathological gamblers. However, despite estimates of significant prevalence and
associations with adverse consequences, relatively little is known about pathological
gambling, particularly its neurobiological underpinnings.
3
Gamblers Anonymous is the most popular intervention for problematic gambling.
The literature suggests that cognitive-behavioral therapy, pharmacotherapy, and
family therapy may be useful in the treating the disorder.
4 Among pharmacothe-
rapies, several studies have suggested the efficacy and tolerability of the selective
serotonin reuptake inhibitor (SSRI), especially fluvoxamine, in the treatment of
pathological gambling.
5
We hypothesized that functional MRI (fMRI), which has been shown to provide
some clues to the underlying neurobiology of pathological gambling,
6 might be
useful in monitoring the results of pharmacotherapy. Herein, we report a patho-
logical gambling patient whose improvement with fluvoxamine treatment was
monitored by using fMRI. 
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Legalized gambling is a growing industry, and is probably a factor in the presently increasing prevalence of
pathological gambling. We present a case of a 36-year-old pathological gambler who was treated with fluvoxamine,
a selective serotonin reuptake inhibitor, and who was assessed by functional MRI before and after drug
administration. During activation periods, the pathological gambler was shown cards as stimuli, and fMRI results in
several brain regions showed differential effects before and after medication and a maintenance period. This case
demonstrates that the treatment response to fluvoxamine in a pathological gambler was observed not only by
subjective self-report, but also by objective fMRI results. Therefore, fMRI may be a useful tool in the diagnosis and
prediction of treatment response in patients afflicted with pathological gambling. 
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pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 50(3): 441-444, 2009A 36-year-old married man was admitted for his malada-
ptive gambling behavior, suicide attempt, and depressive
mood. He had taken over his father’s business and had
worked successfully as the president of a ready-mixed
concrete cooperation until he fell into gambling. This hap-
pened when he lost more than 13 billion won (about 1.4
million US$) because of a downward trend in the stock
market. He struggled and made every effort to recover his
loss. When he went to a casino while vacationing with a
friend, he gambled forty million won that he had, and he
succeeded twice. Since that time, he began to visit the casino
after finishing business early in the morning. The frequency
of his visits increased rapidly, and he eventually visited this
casino almost daily by the end of the year 2000. He played
mostly ‘baccarat’ and rarely played slot machines or any
other type of game. His family members and employees did
not know about his repeated and maladaptive gambling
behavior because he concealed it from them. As his gambl-
ing continued, he lost money more frequently. However, he
could not control his desire to recover all of his losses at
once. As time passed, his financial losses continued to
increase, and he lost not only part of his father’s property,
but also fell into debt to his friends. He attempted suicide by
hanging himself in his house in the autumn of 2001, at
which point his family became aware of his maladaptive
gambling behavior. His gambling behavior continued for
more two years, and his suicidal thoughts, attempts, and
depressive mood caused his mother and brother to take him
to the Depressive Disorder Clinic, Department of Psychiatry,
Chonbuk National University Hospital, Jeonju, Korea. He
was voluntarily admitted to the psychiatric ward at Chon-
buk National University Hospital in February 2002.
There were no psychiatric disorders including patholo-
gical gambling, substance abuse, or depression among his
family and relatives. In the first interview after admission,
he appeared physically healthy, but somewhat tense and
confused by his abrupt admission. He felt guilty about his
gambling behavior, especially toward his parents, In an
unreasonable belief, however, he insisted that he could regain
his gambling losses by gambling again. He had not been
addicted to alcohol or other substances and demonstrated no
other impulsive behaviors (e.g. sexual, aggressive). However,
he was a heavy smoker at two packs a day. 
Immediately after admission, his laboratory results were
found to be in the normal range; complete blood count
(CBC), liver function test (LFT), urine analysis, thyroid
function test (TFT), venereal disease research laboratory
(VDRL) test, electrocariogram (EKG), chest X-ray, and
other routine laboratory tests. His blood pressure was
130/80 mmHg; and respiration and other physical findings
were in the normal range. 
Without any medication, he was examined for mood,
thought, behavior, and craving for gambling one week after
admission. He had a score of 10 in the Korean South Oaks
Gambling Screening (KSOGS),
7 and a score of 18 in the
Gambling Symptom Assessment Scales (GSAS). According
to the DSM-IV-TR, he met the criteria for pathological
gambling. He did not meet the DSM-IV-TR criteria for major
depressive disorder, but he met the criteria for dysthymic
disorder. 
Baseline imaging was obtained by fMRI on the seventh
day after admission (Fig. 1). On the eighth day, fluvoxamine
(50 mg/day) was prescribed for him with no concomitant
mediations. In the three weeks after admission, the dose of
fluvoxamine was raised to 200 mg/day and maintained
during a follow-up period; there were no significant adverse
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Fig. 1. fMRI before fluvoxamine administration. This figure shows the difference
between the activation and resting conditions. The brain is generally activated,
especially in both parietal regions and the occipital, and frontal regions.
Fig. 2. fMRI one week after fluvoxamine administration. The figure shows the
difference between the activation and resting conditions. There is no activated
region in the occipital and temporal areas. There were activated regions in both
frontal (right: Brodmann’s areas 6, 5, and 4; left: Brodmann’s areas 6, 4) and both
parietal (right: Brodmann’s area 7; left: Brodmann's areas 7, 19) lobes. effects of the medication. Beck’s Depression Inventory
(BDI), State-Trait Anxiety Inventory (STAI), and GSAS
had been administered before medication, and they were re-
examined on the seventh day after medication. The second
fMRI scan was also obtained on the seventh day after
medication (Fig. 2). 
Three weeks after discharge (six weeks after beginning of
the fluvoxamine prescription), BDI, STAI, and GSAS were
again administered, and the same assessments were also
carried out at six and nine months after beginning of the
medication (Table 1). Additionally, fMRI scans took place
at six weeks and six months after medication (Figs. 3 and 4). 
The patient did not undergo individual or group cognitive
behavioral therapy, nor did he participate in Gamblers
Anonymous during or after his admission to the hospital.
He had not gone to gamble during the follow-up period. He
also had reported that his desire to gamble had decreased,
and he was disabused of his unreasonable belief that he
could regain his losses by gambling. He presently main-
tained his job and social relationships stably after treatment. 
fMRI was performed on a 1.5T magnetic resonance
scanner (Magnetom VISION, Siemens, Erlangen, Germany).
For functional imaging, echo-planar imaging (EPI) was
used (matrix = 64×64). Five rest conditions were alternated
with five activation conditions, and each period consisted of
120 images at 22-second intervals (repetition time). These
1,200 images were collected and analyzed according to the
time. During the activation period, the stimuli consisted of
card pictures showing a full house, four-of-a-kind, and a
royal straight flush. During the resting period, the patient
was shown landscape pictures. Analysis of the images from
the activation period was performed using SPM 99 statistical
parametric mapping software to establish reference vectors
corresponding to activation and resting periods. Among
regions in which changes in signal intensity were cross-
correlated with the reference vector, only regions meeting a
threshold of p = .0001 and an extent threshold of 30 voxels
(size 2×2×2 mm) were considered as significant signals.
The anatomical locations of the activated foci were assigned
using the Talairach atlas and were then presented as the
appropriate Brodmann’s areas.  
Sociological and individual factors have been implicated in
the development and maintenance of pathological gambling
behavior. Recently, the etiology of pathological gambling
has been suggested to involve abnormalities in certain
neurotransmitters. Although an understanding of the neu-
robiology of pathological gambling is still in its infancy,
several recent studies support these theories. Dysfunction of
fMRI and Pathological Gambling
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Fig. 3. fMRI six weeks after fluvoxamine administration. The figure shows the
difference between the activation and resting conditions. There were activated
regions in the left frontal (Brodmann’s area 6), right parietal (Brodmann’s areas 7,
40), and left parietal (Brodmann’s areas 7, 19, and 40) lobes. 
Fig. 4. fMRI six months after fluvoxamine administration. The figure shows the
difference between the activation and resting conditions. The previously activated
regions were generally decreased. There were small activated regions in the right
frontal lobe (Brodmann’s area 6), left occipital lobe (Brodmann’s areas 18, 19), right
limbic area (Brodmann’s area 24), and left limbic area (Brodmann’s area 31).  DISCUSSION
Table 1.Changes in Study Measures of the Patient with Pathological Gambling Treated with Fluvoxamine
Baseline 1 week* 6 weeks* 6 months* 9 months*
BDI 38 36 30 26 25
STAI 54, 52 54, 48 50, 45 42, 43 48, 44
GSAS 48 30 18 8 4
BDI, Beck’s depression inventory; STAI, State-Trait Anxiety Inventory; GSAS, Gambling Symptom Assessment Scales. 
*After administration of fluvoxamine. Sang-Keun Chung, et al.




the serotonergic system has been linked to impulsive and
compulsive traits in pathological gamblers.
8 In addition,
serotonin is associated with behavioral initiation and disin-
hibition, which may disrupt one’s ability to stop gambling,
thus playing an important role in the gambling cycle.
9,10
Ventral prefrontal regions may be an important interface
between the cognitive and emotional components of risk-
taking behaviors.
11 Also, functional imaging studies using
infusions of nicotine or cocaine have shown associations
between the rewarding effects of these drugs and the neu-
rons in the nucleus accumbens, brainstem, amygdala, and
prefrontal cortices.
12,13 These regions may be linked to the
addictive symptoms of pathological gambling. In our case,
the significant decrease in the generally activated regions
after administration of fluvoxamine coincided with the
decreased desire to gamble, despite subjective measures of
a slightly depressive mood according to BDI. It should be
demonstrated in further studies whether the significant
decrease of activation in different brain regions is correlated
with the therapeutic effects of fluvoxamine.
Examination of the neural correlates of treatment of
pathological gambling with selective serotonin reuptake
inhibitors seems particularly intriguing because of data sug-
gesting the efficacy and tolerability of these drugs in the
short-term treatment of pathological gambling, and because
of the effects of these drugs on cortico-basal-ganglionic-
thalamic activity in OCD.
14,15
In this case, the responses to pharmacotherapy with
fluvoxamine in a patient suffering from pathological gam-
bling were observed not only by symptomatic self-report,
but also by the objective measure of brain functional MRI.
However, a question of whether the improvement of patho-
logical gambling symptoms in this case was secondary to
improvement of a co-morbid condition remains unanswered.
Furthermore, fMRI findings could not be evaluated on the
basis of precise correlation between regions showing differ-
ences and symptoms of pathological gambling. In spite of
these limitations, the present study combined brain fMRI
and pharmacotherapeutical findings of pathological gamb-
ling, providing an indication of the usefulness of fMRI as a
diagnostic tool and predictor of treatment response in a
pathological gambler. More research testing this hypothesis
may deepen our knowledge about the prevention, diagnosis,
and treatment of pathological gambling. 
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